Algert Global LLC Eiger Bio Pharmaceuticals, Inc. Transaction History

Algert Global LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$5.12 - $8.19 $169,431 - $271,023	-33,092 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$6.68 - $9.1 $11,663 - $15,888	-1,746 Reduced 5.01%	33,092 $221,000
Q2 2021 Aug 13, 2021	SELL	$7.82 - $9.23 $34,486 - $40,704	-4,410 Reduced 11.24%	34,838 $297,000
Q1 2021 May 14, 2021	SELL	$8.44 - $12.66 $488,338 - $732,507	-57,860 Reduced 59.58%	39,248 $347,000
Q4 2020 Feb 12, 2021	SELL	$7.98 - $12.29 $3,910 - $6,022	-490 Reduced 0.5%	97,108 $1.19 Million
Q3 2020 Nov 16, 2020	BUY	$7.96 - $12.42 $477 - $745	60 Added 0.06%	97,598 $794,000
Q2 2020 Aug 12, 2020	SELL	$5.4 - $13.37 $36,234 - $89,712	-6,710 Reduced 6.44%	97,538 $936,000
Q1 2020 May 13, 2020	BUY	$4.91 - $14.7 $252,226 - $755,139	51,370 Added 97.15%	104,248 $709,000
Q4 2019 Feb 18, 2020	BUY	$9.77 - $15.66 $58,326 - $93,490	5,970 Added 12.73%	52,878 $788,000
Q3 2019 Nov 14, 2019	BUY	$9.59 - $12.0 $173,943 - $217,656	18,138 Added 63.04%	46,908 $481,000
Q2 2019 Aug 14, 2019	BUY	$9.54 - $14.96 $106,237 - $166,594	11,136 Added 63.15%	28,770 $305,000
Q1 2019 May 01, 2019	SELL	$10.31 - $14.38 $416,802 - $581,340	-40,427 Reduced 69.63%	17,634 $247,000
Q4 2018 Feb 01, 2019	SELL	$8.63 - $12.4 $85,091 - $122,264	-9,860 Reduced 14.52%	58,061 $590,000
Q3 2018 Nov 14, 2018	BUY	$9.6 - $12.9 $433,996 - $583,183	45,208 Added 199.04%	67,921 $815,000
Q2 2018 Aug 02, 2018	BUY	$8.3 - $16.8 $188,517 - $381,578	22,713 New	22,713 $277,000

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $418M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.